Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 7/20 | 0.43 |
| ▸ | CA1 | P00915 | 6/20 | 0.43 |
| ▸ | CA9 | Q16790 | 1/20 | 0.32 |
| ▸ | CA7 | P43166 | 1/20 | 0.30 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1032931 | 0.86 | CA2 (0.47) | CA2CA1CA9CA7CA13 | |
| SCHEMBL2013370 | 0.85 | CA2 (0.41) | CA2CA1CA9CA7 | |
| SCHEMBL15282824 | 0.82 | CA2 (0.46) | CA2CA1CA9CA7CA13 | |
| SCHEMBL1759312 | 0.82 | CA2 (0.42) | CA2CA1CA9 | |
| SCHEMBL575713 | 0.81 | CA2 (0.44) | CA2CA1CA9CA7 | |
| SCHEMBL576009 | 0.81 | CA2 (0.44) | CA2CA1CA9CA7CA13 | |
| Ammonia Solution, Strong SCHEMBL28986366 | 0.80 | CA2 (0.41) | CA2CA1CA9 | |
| SCHEMBL23291930 | 0.79 | CA2 (0.46) | CA2CA1CA9CA7 | |
| SCHEMBL1759310 | 0.79 | CA2 (0.43) | CA2CA1CA9CA7CA13 | |
| SCHEMBL4952312 | 0.79 | CA2 (0.46) | CA2CA1CA9CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 223 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107275675-A | A kind of nonaqueous lithium ion battery electrolyte and lithium ion battery | 珠海市赛纬电子材料股份有限公司 | 2017-10-20 | — | — | CN | claimed |
| US-8940793-B2 | 4-[(haloalkyl)(dimethyl)ammonio]butanoates and use thereof in the treatment of cardiovascular disease | JSC GRINDEKS (LV) | 2015-01-27 | — | — | US | claimed |
| US-20140107202-A1 | 4-[(haloalkyl)(dimethyl)ammonio]butanoates and use thereof in the treatment of cardiovascular disease | JSC GRINDEKS (LV) | 2014-04-17 | — | — | US | claimed |
| EP-2702037-A1 | 4-[(HALOALKYL)(DIMETHYL)AMMONIO]BUTANOATES AND USE THEREOF IN THE TREATMENT OF CARDIOVASCULAR DISEASE | Grindeks, A Joint Stock Company (LV) | 2014-03-05 | — | — | EP | claimed |
| WO-2012146737-A1 | 4-[(HALOALKYL)(DIMETHYL)AMMONIO]BUTANOATES AND USE THEREOF IN THE TREATMENT OF CARDIOVASCULAR DISEASE | GRINDEKS, A JOINT STOCK COMPANY (LV) | 2012-11-01 | — | — | WO | claimed |
| US-12630516-B2 | Compounds | NRG THERAPEUTICS LTD. (GB) | 2026-05-19 | — | — | US | disclosed |
| EP-4667056-A1 | IKAROS ZINC FINGER FAMILY DEGRADERS AND USES THEREOF | Gilead Sciences, Inc. (US) | 2025-12-24 | — | — | EP | disclosed |
| EP-4208442-B1 | MPTP INHIBITORS | NRG THERAPEUTICS LTD (GB) | 2025-10-22 | — | — | EP | disclosed |
| US-20250179028-A1 | ACRYLAMIDE COMPOUNDS | NRG THERAPEUTICS LTD (GB) | 2025-06-05 | — | — | US | disclosed |
| EP-4486721-A1 | ACRYLAMIDE COMPOUNDS | NRG Therapeutics LTD (GB) | 2025-01-08 | — | — | EP | disclosed |
| US-20240360114-A1 | FERROPTOSIS MODULATORS, PREPARATIONS, AND USES THEREOF | Sironax Ltd. (KY) | 2024-10-31 | — | — | US | disclosed |
| US-12122764-B2 | IKAROS zinc finger family degraders and uses thereof | GILEAD SCIENCES, INC. (US) | 2024-10-22 | — | — | US | disclosed |
| WO-2002102250-A1 | $G(IN VIVO) IMAGING | GLAXO GROUP LIMITED (GB) | 2002-12-27 | — | — | WO | disclosed |
| EP-1022279-B1 | NEW CARBAPENEM DERIVATIVES | MEIJI SEIKA KAISHA (JP) | 2002-09-04 | — | — | EP | disclosed |
| CN-1081641-C | Carbapenem derivatives and antimicrobials | MEIJI SEIKA KAISHA (JP) | 2002-03-27 | — | — | CN | disclosed |
| US-6180622-B1 | ANTIMICROBIAL ACTIVITY AGAINST A WIDE RANGE OF BACTERIA INCLUDING GRAM-POSITIVE BACTERIA, GRAM-NEGATIVE BACTERIA, BETA-LACTAMASE-PRODUCING BACTERIA, RESISTANT PSEUDOMONAS AERUGINOSA,METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS AND | MEIJI SEIKA KAISHA, LTD. (JP) | 2001-01-30 | — | — | US | disclosed |
| EP-1022279-A1 | NEW CARBAPENEM DERIVATIVES | MEIJI SEIKA KAISHA LTD. (JP) | 2000-07-26 | — | — | EP | disclosed |
| CN-1244868-A | Novel carbapenem derivative | MEIJI SEIKA KAISHA (JP) | 2000-02-16 | — | — | CN | disclosed |
| CN-1209810-A | Carbapenem derivative and antibacterial agent | MEIJI SEIKA KAISHA (JP) | 1999-03-03 | — | — | CN | disclosed |
| EP-0887352-A1 | CARBAPENEM DERIVATIVES AND ANTIMICROBIALS | MEIJI SEIKA KAISHA LTD. (JP) | 1998-12-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12630516-B2 | Compounds | CYP4B1, CYP1B1, NR4A1 | CA2 1919/4885CA1 754/4885CA9 920/4885 |
| US-20140107202-A1 | 4-[(haloalkyl)(dimethyl)ammonio]butanoates and use thereof in the treatment of cardiovascular disease | FABP3, HCN3, HCN4 | CA2 704/4885CA1 997/4885CA9 1240/4885 |
| US-20240360114-A1 | FERROPTOSIS MODULATORS, PREPARATIONS, AND USES THEREOF | AIFM2, GPX1, GPX4 | CA2 2405/4885CA1 3220/4885CA9 3943/4885 |
| US-20250179028-A1 | ACRYLAMIDE COMPOUNDS | ACR, CCNI, FANCI | CA2 1928/4885CA1 661/4885CA9 1070/4885 |
| US-12122764-B2 | IKAROS zinc finger family degraders and uses thereof | IKZF2, IKZF1, IKZF3 | CA2 3263/4885CA1 3665/4885CA9 4415/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.